Friday January 22, 2021 0 comments
BOULDER -- AGC Biologics announced a new appointment to oversee the startup, strategic development and operational excellence in large-scale biologics production at its Boulder site.
Effective Feb. 1, David Stewart will join the Boulder team as general manager/site head.
AGC said Stewart brings a servant leader mindset, with a proven record of delivering best-in-class supply for client organizations and the patients they serve.
Stewart promotes accountability, innovation, collaboration, and agility to build high-performance teams, AGC said. He also brings more than 20 years of leadership experience in the biotechnology and manufacturing industry, including roles with Biogen and Genentech.
In his new role, Stewart will support the continuous growth of the Boulder site while partnering closely with colleagues across AGC Biologics' global network of facilities to bring new biopharmaceuticals to market.
"We are very happy that Mr. Stewart is joining us as general manager/site head for the Boulder site,” said AGC Biologics Chief Technical Officer Kasper Møller.
“He brings broad experience and demonstrated leadership ability from large-scale biologics drug substance operations. I am confident that Mr. Stewart will lead the Boulder site to successful operations in support of our customers' growing demands."